Syndecan-1 Expression on Malignant Cells from the Blood and Marrow of Patients with Plasma Cell Proliferative Disorders and B-Cell Chronic Lymphocytic Leukemia

References

• Berenson J., Wong R., Kim K., Brown N., Liechtenstein A. Evidence for peripheral blood B lymphocyte but not T-lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Billadeau D., Quam L., Thomas W., Kay N., Greipp P., Kyle R., Oken M., Van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818–1824
   PubMed Web of Science ®Google Scholar
• Billadeau D., Van Ness B., Kimlinger T., Kyle R., Therneau T., Greipp P., Witzig T. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 1996; 88: 289–296
   PubMed Web of Science ®Google Scholar
• Witzig T., Gertz M., Lust J., Kyle R., O'Fallon W., Greipp P. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 1996; 88: 1780–1787
   PubMed Web of Science ®Google Scholar
• Bemfield M., Kokenyesi R., Kato M., Hinkes M., Spring J., Gallo R., Lose E. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology 1992; 8: 365–393
   PubMedGoogle Scholar
• Sanderson R., Lalor P., Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regulation 1989; 1: 27–35
   PubMedGoogle Scholar
• Wijdenes L., Vooijs W., Clément C., Post J., Morad F., Vita N., Laurent P., Sun R.-X., Klein B., Dore J.-M. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Haematology 1996; 94: 318–323
   PubMed Web of Science ®Google Scholar
• Ridley R., Xiao H., Hata H., Woodliff J., Epstein J., Sanderson R. Expression of syndecan regulates human myeloma plasma cell adhesion to type 1 collagen. Blood 1993; 81: 767–774
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Bataille R., Robillard N., Harousseau J.-L., Rapp M.-J., Juge-Morineau N., Wijdenes J., Amiot M. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 1994; 84: 2597–2603
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Barille S., Puthier D., Rapp M.-J., Harousseau J-L., Bataille R., Amiot M. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Research 1995; 55: 3647–3653
   PubMed Web of Science ®Google Scholar
• Rawstron A., Owen R., Davies F., Johnson R., Jones R., Richards S., Evans P., Child J., Smith G., Jack A., Morgan G. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Haematology 1997; 97: 46–55
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gattei V., Degan M., Improta S., Aldinucci D., Canzonieri V., Perin T., Volpe R., Gaidano G., Zagonel V., Pinto A. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 1997; 89: 3787–3794
   PubMed Web of Science ®Google Scholar
• Baird A. Potential mechanisms regulating the extracellular activities of basic fibroblast growth factor (FGF-2). Molecular Reproduction and Development 1994; 39: 43–48
   PubMed Web of Science ®Google Scholar
• Yayon A., Klagsbrun M., Esko J., Leder P., Ornitz D. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848
   PubMed Web of Science ®Google Scholar
• Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Advances in Cancer Research 1992; 59: 115–165
   PubMed Web of Science ®Google Scholar
• Steinfeld R., Van Den Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypi-can. Journal of Cell Biology 1996; 133: 405–416
   PubMed Web of Science ®Google Scholar
• Menzel T., Rahman Z., Calleja E., White K., Wilson E., Wieder R., Gabrilove J. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 1996; 87: 1056–1063
   PubMed Web of Science ®Google Scholar
• Hata H., Xiao H., Petrucci M., Woodliff J., Chang R., Epstein J. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 1993; 81: 3357–3364
   PubMed Web of Science ®Google Scholar
• Kawano M., Huang N., Harada H., Harada Y., Sakai A., Tanaka H., Iwato K., Kuramoto A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993; 82: 564–570
   PubMed Web of Science ®Google Scholar
• Westendorf J., Ahmannn G., Armitage R., Spriggs M., Lust J., Greipp P., Katzmann J., Jelinek D. CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. Journal of Immunology 1994; 152: 117–128
   PubMed Web of Science ®Google Scholar
• Witzig T., Kimlinger T., Ahmann G., Katzmann J., Greipp P. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996; 26: 113–120
   PubMedGoogle Scholar
• Kyle R. “Benign” monoclonal gammopathy after 20-35 years of follow-up. Mayo Clinic Proceedings 1993; 68: 26–36
   PubMed Web of Science ®Google Scholar
• Gertz M., Witzig T., Pineda A., Greipp P., Kyle R., Litzow M. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplantation 1997; 19: 337–342
   PubMed Web of Science ®Google Scholar
• Schneider U., Van Lessen A., Huhn D., Serke S. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. British Journal of Haematology 1997; 97: 56–64
   PubMed Web of Science ®Google Scholar
• Myoken Y., Myoken Y., Okamoto T., Sato J., Kan M., McKeehan W., Nakahara M., Takada K. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 inhuman malignant salivary gland tumours. Journal of Pathology 1996; 178: 429–436
   PubMed Web of Science ®Google Scholar
• Allouche M., Bayard F., Clamens S., Fillola G., Sié P., Amalric F. Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 1995; 9: 77–86
   PubMed Web of Science ®Google Scholar
• Fuks Z., Persaud R., Alfieri A., McLoughlin M., Ehleiter D., Schwartz J., Seddon A., Cordon-Cardo C., Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Research 1994; 54: 2582–2590
   PubMed Web of Science ®Google Scholar